Datopotamab deruxtecan (Dato-DXd) in Chinese patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Results from the phase 1/2 TROPION-PanTumor02 study.

Sun, Yuping, Xiao, Zuke, Cheng, Ying · Journal of Clinical Oncology · 2024